Radiographic Evaluation in Alveolar Preservation Using Platelet-rich Fibrin. Randomized Controlled Trial
Launched by UNIVERSIDAD CATÓLICA DE CUENCA · Mar 21, 2025
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
This study is a randomized controlled clinical trial designed to investigate the application of platelet-rich fibrin (PRF) in post-extraction sites following orthodontically indicated premolar removals. PRF is prepared from autologous blood and applied to extraction sockets in the experimental group, while the control group undergoes standard physiological healing. Cone beam computed tomography (CBCT) will be used to obtain quantitative data on alveolar bone structure at baseline, 30 days, and 120 days post-extraction. The study will assess changes in bone height, horizontal ridge width at ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy individuals with no systemic diseases.
- • Age range: 17 to 38 years old.
- • Orthodontic indication for premolar extraction (two maxillary or two mandibular premolars).
- • Candidates for orthognathic surgery or extraction of impacted/retained teeth (e.g., third molars with a relationship to critical anatomical structures).
- • Clinical justification for CBCT imaging instead of standard radiographic -techniques.
- Exclusion Criteria:
- • Patients with systemic diseases that may alter periodontal therapy outcomes.
- • Platelet count below 200,000 mm³.
- • Immunosuppressed patients.
- • Pregnant or lactating women.
- • Smokers.
- • Patients taking medications that interfere with healing (e.g., bisphosphonates, corticosteroids, anticoagulants).
About Universidad Católica De Cuenca
Universidad Católica de Cuenca is a distinguished academic institution located in Ecuador, renowned for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research initiatives aimed at improving patient outcomes and contributing to the scientific community. With a focus on ethical standards and rigorous methodology, Universidad Católica de Cuenca collaborates with healthcare professionals and researchers to explore novel therapeutic approaches, ensuring that its clinical trials adhere to the highest quality and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cuenca, Azuay, Ecuador
Patients applied
Trial Officials
ROCIO MAGDALENA MOLINA BARAHONA, Doctor of Dental Surgery (DDS)
Principal Investigator
Universidad Católica de Cuenca
RENATA A AVECILLAS RODAS, Doctor of Dental Surgery (DDS)
Study Chair
Universidad Católica de Cuenca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported